Specialty Pharmacy

The FDA has issued disease-specific draft guidances for the development of gene therapies for certain conditions.

Mobile health interventions have the potential to help people living with HIV improve engagement in care, promote medication adherence, and in turn, improve patient outcomes.

A look at last week's top stories in the world of pharmacy.

Nivolumab (Opdivo) plus ipilimumab (Yervoy) approved for patients with microsatellite instability high or mismatch repair deficient metastatic colorectal cancer that has progressed following treatment with a fluoropyrimidine, oxaliplatin, and irinotecan.

Research to explore whether intermittent fasting can improve symptoms in patients with relapsing-remitting multiple sclerosis.

Olaparib (Lynparza, Merck and AstraZeneca) demonstrated significant improvement in progression-free survival in the first-line maintenance setting for women with advanced BRCA-mutated ovarian cancer.

Top news of the day from across the health care landscape.

Hepatocellular carcinoma is the most common type of liver cancer in adults.

Even as fewer patients are using them, the 10 medications with the highest spend in Medicare Part D have seen substantial increases in spending and out-of-pocket costs.

Results from a phase 3 study and post-hoc analysis highlight the use of galcanezumab-gnlm (Emgality, Eli Lilly) for the treatment of episodic cluster headache and migraine.

The updated labeling will strengthen warnings for mental health adverse effects and risks related to hypoglycemia.

Top news of the day from across the health care landscape.

New research identified predictors of long-term survival and health-related quality of life in patients with newly diagnosed multiple myeloma.

Pharmaceutical manufacturers depend on hubs to act as connectors between various stakeholders across the specialty drug prescribing process.

The PALOMA-3 trial evaluated palbociclib (Ibrance) in combination with fulvestrant in women with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer.

The American Journal of Medicine has published a new article that describes the reemergence of neurosyphilis and identifies HIV coinfection in individuals in Western countries as a key risk factor.

A new, inexpensive diagnostic test can help identify patients who require immediate treatment for hepatitis B virus across Africa.

Top news of the day from across the health care landscape.

Multiple sclerosis risk increased significantly in individuals with occupational exposure to organic solvents.

Luis Torres, MBA, Vice President, Managed Care, BioPlus Specialty Pharmacy, speaks about why data is a crucial component of choosing a specialty pharmacy.

Researchers have developed a laser-sonic scanner with the ability to detect tumors in as little as 15 seconds.

New study results indicate that an experimental mosaic HIV vaccine may have the potential to protect against a wide-range of global HIV strains.

Top news of the day from across the health care landscape.

Study suggests that super receptors on immune cells can eliminate HIV among genetically diverse patients.

New research suggests psychiatric diseases that affect a patient’s ability to appropriately respond to stimuli may be triggered by the misplacement of an enzyme in the pathway within neurons.

A look at last week's top stories in the world of pharmacy.

Top news of the day from across the health care landscape.

Top news of the week from Specialty Pharmacy Times.

IncobotulinumtoxinA is the first and only neurotoxin approved for this indication in the United States.

Using a DNA test to identify genetic variants in men that increase the likelihood of prostate cancer may help guide interventions for those at high risk and improve disease prevention.